RO 5840-0005

Stipend and Dates

Up to $10,595 (multiple payments)

Note: You cannot pick which group you go into. The first group is filled before patients are placed in the next group.	Group 6	Cohort 7
Admit	May 30, 2022 Mon	Jun 13, 2022 Mon
Discharge	Jun 02, 2022 Thurs	Jun 16, 2022 Thurs
Day 4 Outpatient visit	Jun 03	Jun 17
Day 5 Outpatient visit	Jun 04	Jun 18
Day 6 Outpatient visit	Jun 05	Jun 19
Day 7 Outpatient visit	Jun 06	Jun 20
Day 8 Outpatient visit - a payment within 10 business days	Jun 07	Jun 21
Day 12 Outpatient visit	Jun 11	Jun 25
Day 21 Outpatient visit	Jun 20	Jul 04
Day 29 Outpatient visit	Jun 28	Jul 12
Day 43 Outpatient visit - a payment within 10 business days	Jul 12	Jul 26
Day 64 Outpatient visit	Aug 02	Aug 16
Day 90 Outpatient visit - a payment within 10 business days	Aug 28	Sep 11

 

Click here to make an appointment for RO 5840-0005

Or call 210-225-5437 for more information

 

Study Criteria

Healthy Males and Females

Age:  18-80

BMI and Weight:  18 to 32 kg/m2                121 TO 242 pounds

Lower Abdominal area:  no abnormal skin conditions, tattoos, lesions, etc.

* Please note- If Qualified, you will be required to have an MRI (Magnetic Resonance Imaging) Scan of the brain.

 

Study Information

Indication: The investigational drug is being developed as a potential treatment of Alzheimer’s disease.

Route of Administration: SC (Sub-cutaneous)  injection under the skin of the abdomen

Washout from previous study: Participation in an investigational drug product or medical device within 30 days before dosing.

Acceptable Birth Control for Females (if Childbearing):  Child bearing women who are able to become pregnant and not practicing sexual abstinence must agree to use a highly effective method of contraception in addition to a barrier method (male condom), during the study and for at least 17 weeks after the study drug dose:

Acceptable methods of birth control for use in this study are:

• Intrauterine Device(s) (IUD)
• Hormonal Contraceptives:
• Implants
• Hormone shot/injection
• Oral Contraceptives
• Vaginal ring
• Bilateral tubal ligation
• Male partner vasectomy

 Females in the following categories are considered non-childbearing:

• Documented hysterectomy (removal of uterus), bilateral salpingectomy (removal of both Fallopian tubes) or bilateral oophorectomy (removal of both ovaries)
• Menopause more than one year prior to study entry (stopped having monthly menstrual periods more than one year ago) and confirmed at screening by a hormone test.

 

Study Reminders

• 8 hours fasting is required for lab work (only water is allowed)
• If taking medications, bring them to your screening appointment (including prescription, over the counter, herbal supplements and vitamins)
• Bring a valid, non-expired photo ID with you when you attend your screening visit.  We accept a valid government issued identification card such as a driver's license, state issued ID card or passport.  You will be required to show this same photo ID at all study visits
• Arrive 30 minutes before your appointment to complete paper work.